Dynacure Announces First Patient Dosed in Phase 1 / 2 ‘UNITE-CNM’ Study of DYN101...

Dynacure Announces First Patient Dosed in Phase 1 / 2 'UNITE-CNM' Study of DYN101 for the Treatment of Myotubular and Centronuclear Myopathies (CNM)

Zhimeng Biopharma Announces the First-in-Human Dosing in Phase I Clinical Trial of ZM-H1505R Designed...

Zhimeng Biopharma Announces the First-in-Human Dosing in Phase I Clinical Trial of ZM-H1505R Designed for the Treatment of Chronic Hepatitis B Virus Infection

TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug...

TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug Administration for the Treatment of Follicular Lymphoma

Can-Fite Updates on Clinical Milestone for its Phase III Rheumatoid Arthritis Study with Piclidenoson;...

Can-Fite Updates on Clinical Milestone for its Phase III Rheumatoid Arthritis Study with Piclidenoson; Drugs Combating Rheumatoid Arthritis are Currently Introduced for the Treatment...

Allergan’s Durysta becomes first intracameral implant cleared in US to reduce eye pressure

Allergan's Durysta becomes first intracameral implant cleared in US to reduce eye pressure
- Advertisement -

LATEST NEWS

MUST READ